KEVINFISHERKEVIN FISHER7942FISHER, KEVINAssociate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 1565631Authorship 156641317156449Fisher KE, Pop A, Koh W, Anthis NJ, Saunders WB, Davis GEMolecular cancerTumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling. Mol Cancer. 2006 Dec 08; 5:69.Mol Cancer2006-12-08T00:00:002006Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.22760605Fisher SB, Fisher KE, Patel SH, Lim MG, Kooby DA, El-Rayes BF, Staley CA, Adsay NV, Farris AB, Maithel SKCancerExcision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy. Cancer. 2013 Jan 15; 119(2):454-62.Cancer2012-07-03T00:00:002012Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy.23719746Squires MH, Fisher SB, Fisher KE, Patel SH, Kooby DA, El-Rayes BF, Staley CA, Farris AB, Maithel SKCancerDifferential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma. Cancer. 2013 Sep 01; 119(17):3242-50.Cancer2013-05-29T00:00:002013Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma.23746767Fisher KE, Jani JC, Fisher SB, Foulks C, Hill CE, Weber CJ, Cohen C, Sharma JThe Journal of surgical researchEpidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma. J Surg Res. 2013 Nov; 185(1):217-24.J Surg Res2013-05-23T00:00:002013Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.23887297Fisher KE, Yin-Goen Q, Alexis D, Sirintrapun JS, Harrison W, Benjamin Isett R, Rossi MR, Moreno CS, Young AN, Osunkoya AOModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncGene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Mod Pathol. 2014 Feb; 27(2):222-30.Mod Pathol2013-07-26T00:00:002013Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.24074812Fisher SB, Baxter KJ, Staley CA, Fisher KE, Monson DK, Murray DR, Oskouei SV, Weiss SW, Kooby DA, Maithel SK, Delman KAJournal of the American College of SurgeonsThe General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist? J Am Coll Surg. 2013 Nov; 217(5):881-8.J Am Coll Surg2013-09-25T00:00:002013The General Surgeon's quandary: atypical lipomatous tumor vs lipoma, who needs a surgical oncologist?24122802Fisher SB, Fisher KE, Squires MH, Patel SH, Kooby DA, El-Rayes BF, Cardona K, Russell MC, Staley CA, Farris AB, Maithel SKJournal of surgical oncologyHER2 in resected gastric cancer: Is there prognostic value? J Surg Oncol. 2014 Feb; 109(2):61-6.J Surg Oncol2013-10-10T00:00:002013HER2 in resected gastric cancer: Is there prognostic value?24570902Fisher SB, Fisher KE, Maithel SKHepatobiliary surgery and nutritionMolecular targeted therapy for biliary tract malignancy: defining the target. Hepatobiliary Surg Nutr. 2012 Dec; 1(1):53-4.Hepatobiliary Surg Nutr2012-12-01T00:00:002012Molecular targeted therapy for biliary tract malignancy: defining the target.24897065Fisher KE, Neill SG, Ehsani L, Caltharp SA, Siddiqui MT, Cohen CApplied immunohistochemistry & molecular morphology : AIMMImmunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies. Appl Immunohistochem Mol Morphol. 2014 Sep; 22(8):562-7.Appl Immunohistochem Mol Morphol2014-09-01T00:00:002014Immunohistochemical Investigation of BRAF p.V600E mutations in thyroid carcinoma using 2 separate BRAF antibodies.25046227Ehsani L, Cohen C, Fisher KE, Siddiqui MTApplied immunohistochemistry & molecular morphology : AIMMBRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression. Appl Immunohistochem Mol Morphol. 2014 Oct; 22(9):648-51.Appl Immunohistochem Mol Morphol2014-10-01T00:00:002014BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression.25220586Fisher KE, Neill SG, Smith GH, Pillai RN, Kudchadkar RR, Zhang L, Rossi MRCurrent problems in cancerIntroduction: molecular genomics of cancer: linking diagnostic testing and clinical therapy. Curr Probl Cancer. 2014 Sep-Oct; 38(5):142-3.Curr Probl Cancer2014-08-14T00:00:002014Introduction: molecular genomics of cancer: linking diagnostic testing and clinical therapy.25228337Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH, Longshore JWHuman pathologyAccurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Hum Pathol. 2014 Nov; 45(11):2281-93.Hum Pathol2014-08-07T00:00:002014Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.25239561Zhang L, Rossi MR, Fisher KECurrent problems in cancerSection II: hematolymphoid malignancies. Curr Probl Cancer. 2014 Sep-Oct; 38(5):159-74.Curr Probl Cancer2014-08-14T00:00:002014Section II: hematolymphoid malignancies.25239562Fisher KE, Smith GH, Neill SG, Rossi MRCurrent problems in cancerSection I: integrating laboratory medicine with tissue specimens. Curr Probl Cancer. 2014 Sep-Oct; 38(5):144-58.Curr Probl Cancer2014-08-14T00:00:002014Section I: integrating laboratory medicine with tissue specimens.25281457Fisher KE, Pillai RN, Kudchadkar RR, Rossi MRCurrent problems in cancerSection IV: non-small cell lung cancer and malignant melanoma. Curr Probl Cancer. 2014 Sep-Oct; 38(5):180-98.Curr Probl Cancer2014-08-14T00:00:002014Section IV: non-small cell lung cancer and malignant melanoma.Authorship 162725225265433Sullivan HC, Fisher KE, Hoffa AL, Wang J, Saxe D, Siddiqui MT, Cohen CApplied immunohistochemistry & molecular morphology : AIMMThe role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer. Appl Immunohistochem Mol Morphol. 2015 Apr; 23(4):239-44.Appl Immunohistochem Mol Morphol2015-04-01T00:00:002015The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer.HematopathologyInvestigational Cancer TherapeuticsLeukemiaTranslational Molecular PathologyMD AndersonVIVEKSUBBIAHVIVEK SUBBIAH9518SUBBIAH, VIVEKAssistant ProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorL JEFFREYMEDEIROSL JEFFREY MEDEIROS8762MEDEIROS, L JEFFREYProfessorVICTORPRIETOVICTOR PRIETO8828PRIETO, VICTORProfessorIGNACIO IVANWISTUBAIGNACIO IVAN WISTUBA9098WISTUBA, IGNACIO IVANProfessorAuthorship 2994912Authorship 3030771Authorship 3046442225971545Fisher KE, Cohen C, Palma JF, Longshore JWHuman pathologyBRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply. Hum Pathol. 2015 Jul; 46(7):1065-6.Hum Pathol2015-04-11T00:00:002015BRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply.26145173Kang HB, Fan J, Lin R, Elf S, Ji Q, Zhao L, Jin L, Seo JH, Shan C, Arbiser JL, Cohen C, Brat D, Miziorko HM, Kim E, Abdel-Wahab O, Merghoub T, Fr?hling S, Scholl C, Tamayo P, Barbie DA, Zhou L, Pollack BP, Fisher K, Kudchadkar RR, Lawson DH, Sica G, Rossi M, Lonial S, Khoury HJ, Khuri FR, Lee BH, Boggon TJ, He C, Kang S, Chen JMolecular cellMetabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. Mol Cell. 2015 Aug 06; 59(3):345-358.Mol Cell2015-07-02T00:00:002015Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.26486738Maier CL, Fisher KE, Jones HH, Hill CE, Mann KP, Zhang LAmerican journal of clinical pathologyDevelopment and validation of CALR mutation testing for clinical diagnosis. Am J Clin Pathol. 2015 Nov; 144(5):738-45.Am J Clin Pathol2015-11-01T00:00:002015Development and validation of CALR mutation testing for clinical diagnosis.74Professor10Assistant Professor14Associate ProfessorAuthorship 3200153Authorship 320625126535985Hanley KZ, Fadare O, Fisher KE, Atkins KA, Mosunjac MBInternational journal of gynecological pathology : official journal of the International Society of Gynecological PathologistsClinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp. Int J Gynecol Pathol. 2016 May; 35(3):249-55.Int J Gynecol Pathol2016-05-01T00:00:002016Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp.26801070Fisher KE, Zhang L, Wang J, Smith GH, Newman S, Schneider TM, Pillai RN, Kudchadkar RR, Owonikoko TK, Ramalingam SS, Lawson DH, Delman KA, El-Rayes BF, Wilson MM, Sullivan HC, Morrison AS, Balci S, Adsay NV, Gal AA, Sica GL, Saxe DF, Mann KP, Hill CE, Khuri FR, Rossi MRThe Journal of molecular diagnostics : JMDClinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies. J Mol Diagn. 2016 Mar; 18(2):299-315.J Mol Diagn2016-01-20T00:00:002016Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.Authorship 7564581328219109Ballester LY, Cantu MD, Lim KPH, Sarabia SF, Ferguson LS, Renee Webb C, Allen CE, McClain KL, Mohila CA, Punia JN, Roy A, L?pez-Terrada DH, John Hicks M, Fisher KEHematological oncologyThe use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol. 2018 Feb; 36(1):307-315.Hematol Oncol2017-02-20T00:00:002017The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.29296959Fisher KE, Hsu AP, Williams CL, Sayeed H, Merritt BY, Elghetany MT, Holland SM, Bertuch AA, Gramatges MMBlood advancesSomatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency. Blood Adv. 2017 Feb 28; 1(7):443-448.Blood Adv2017-02-27T00:00:002017Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency.Authorship 8802881Authorship 883395529187020Huho AN, Issaq N, Iacobas I, Elghetany TM, L?pez-Terrada D, Fisher KE, Punia JNPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyA Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis. Pediatr Dev Pathol. 2018 Jan-Feb; 21(1):100-104.Pediatr Dev Pathol2017-03-20T00:00:002017A Rare Case of Pediatric Chronic Myelogenous Leukemia Presenting With Severe Thrombocytosis Without Leukocytosis.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate ProfessorD007947Disorders37470.948801Leukemia, Megakaryoblastic, AcuteD048493Chemicals & Drugs32012770.583946Proto-Oncogene Proteins B-rafD014408Chemicals & Drugs1345103150.25428Biomarkers, TumorD002291Disorders2455840.734765Carcinoma, PapillaryD001791Disorders31380.953062Blood Platelet DisordersAuthorship 9316546Authorship 934104730275002David MP, Venkatramani R, Lopez-Terrada DH, Roy A, Patil N, Fisher KECold Spring Harbor molecular case studiesMultimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type. Cold Spring Harb Mol Case Stud. 2018 10; 4(5).Cold Spring Harb Mol Case Stud2018-10-01T00:00:002018Multimodal molecular analysis of an atypical small cell carcinoma of the ovary, hypercalcemic type.30392857Fisher SB, Cote GJ, Bui-Griffith JH, Lu W, Tang X, Hai T, Fisher KE, Williams MD, Wistuba II, Waguespack SG, Dorman CM, Ludwig MS, Graham PH, Perrier ND, Lee JE, Grubbs EGSurgeryGenetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery. 2019 01; 165(1):58-63.Surgery2018-11-02T00:00:002018Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident.PathologyDepartment of Pathology & ImmunologyPathologyBaylor College of MedicineDOLORESLOPEZ-TERRADADOLORES LOPEZ-TERRADA0.000000000000000.000000000000002067LOPEZ-TERRADA, DOLORESProfessorANDREAMARCOGLIESEANDREA MARCOGLIESE0.000000000000000.000000000000002184MARCOGLIESE, ANDREAAssociate ProfessorJYOTINDERPUNIAJYOTINDER PUNIA0.000000000000000.000000000000003943PUNIA, JYOTINDERAssociate ProfessorANGSHUMOYROYANGSHUMOY ROY0.000000000000000.000000000000004422ROY, ANGSHUMOYAssociate ProfessorCHOLADDACURRYCHOLADDA CURRY0.000000000000000.00000000000000462CURRY, CHOLADDAAssociate ProfessorAuthorship 951283531250550Hashmi SK, Punia JN, Marcogliese AN, Gaikwad AS, Fisher KE, Roy A, Rao P, Lopez-Terrada DH, Ringrose J, Loh ML, Niemeyer CM, Rau REPediatric blood & cancerSustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2019 10; 66(10):e27905.Pediatr Blood Cancer2019-06-28T00:00:002019Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.Authorship 955376631510844Gruner SE, Sayeed H, Suarez-Ferguson L, Perez C, Rouce R, Fisher KE, Rau REPediatric hematology and oncologyPonatinib use in two pediatric patients with relapsed Ph?+?ALL with ABL1 kinase domain mutations. Pediatr Hematol Oncol. 2019 11; 36(8):514-519.Pediatr Hematol Oncol2019-09-11T00:00:002019Ponatinib use in two pediatric patients with relapsed Ph?+?ALL with ABL1 kinase domain mutations.Authorship 957400731624068Lindsay H, Scollon S, Reuther J, Voicu H, Rednam SP, Lin FY, Fisher KE, Chintagumpala M, Adesina AM, Parsons DW, Plon SE, Roy ACold Spring Harbor molecular case studiesGermline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency. Cold Spring Harb Mol Case Stud. 2019 10; 5(5).Cold Spring Harb Mol Case Stud2019-10-23T00:00:002019Germline POLE mutation in a child with hypermutated medulloblastoma and features of constitutional mismatch repair deficiency.true1Associate ProfessorAssociate ProfessorAuthorship 9604861331682773Zhou T, Bloomquist MS, Ferguson LS, Reuther J, Marcogliese AN, Elghetany MT, Roy A, Rao PH, Lopez-Terrada DH, Redell MS, Punia JN, Curry CV, Fisher KEPediatric hematology and oncologyPediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis. Pediatr Hematol Oncol. 2020 Feb; 37(1):76-89.Pediatr Hematol Oncol2019-11-04T00:00:002019Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.Authorship 974700431876361Han H, Bertrand KC, Patel KR, Fisher KE, Roy A, Muscal JA, Venkatramani RPediatric blood & cancerBCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney. Pediatr Blood Cancer. 2020 04; 67(4):e28151.Pediatr Blood Cancer2019-12-26T00:00:002019BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.Authorship 9968421032782782Dupuis M, Shen Y, Curcio C, Meis JM, Wang WL, Amini B, Rhines L, Reuther J, Roy A, Fisher KE, Conley AP, Andrew Livingston JClinical sarcoma researchSuccessful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor. Clin Sarcoma Res. 2020; 10:14.Clin Sarcoma Res2020-08-06T00:00:002020Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor.Authorship 997426932815783Amra N, Zarate LV, Punia JN, Mahajan P, Stevens AM, Roy A, Curry CV, Cortes-Santiago N, Fisher KEPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyMediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics. Pediatr Dev Pathol. 2020 Nov-Dec; 23(6):461-466.Pediatr Dev Pathol2020-08-20T00:00:002020Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics.Authorship 998575632876512Yost CM, Gaikwad AS, Parsons DW, Rabin KR, Gant VU, Fisher KE, Marcogliese AN, Schafer ESLeukemia & lymphomaAberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series. Leuk Lymphoma. 2020 12; 61(14):3515-3518.Leuk Lymphoma2020-09-02T00:00:002020Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series.true1Associate ProfessorAssociate Professor34162180Benkli CY, Marcogliese AN, Agrusa JE, Adesina AM, Weiner HL, Fisher KE, Curry CVHaematologicaClinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients. Haematologica. 2021 09 01; 106(9):2533-2536.Haematologica2021-09-01T00:00:002021Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients.Authorship 10238186Authorship 10244871134224514Whitlock RS, Ebare K, Cheng LS, Fishman DS, Mills JL, Nguyen HN, Nuchtern JG, Ruan W, Smith VE, Patel KA, Fisher KE, Vasudevan SAJournal of pediatric hematology/oncologyAngiosarcoma of the Pancreas in a Pediatric Patient With an Activating KDR-Internal Tandem Duplication: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2022 Apr 01; 44(3):e751-e755.J Pediatr Hematol Oncol2022-04-01T00:00:002022Angiosarcoma of the Pancreas in a Pediatric Patient With an Activating KDR-Internal Tandem Duplication: A Case Report and Review of the Literature.Authorship 10315441434651095Mangum R, Reuther J, Bertrand KC, Chandramohan R, Kukreja MK, Paulino AC, Muzny D, Hu J, Gibbs RA, Curry DJ, Malbari F, Chintagumpala MM, Adesina AM, Fisher KE, Mack SC, Plon SE, Roy A, Parsons DW, Lin FYJCO precision oncologyDurable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling. JCO Precis Oncol. 2021; 5.JCO Precis Oncol2021-07-28T00:00:002021Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an NTRK2 Fusion: The Impact of Integrated Genomic Profiling.Authorship 10373051535026696Garcia A, Desrosiers L, Scollon S, Gruner S, Reuther J, Gandhi I, Patil N, Fuller MY, Dai H, Muzny D, Gibbs RA, Bercaw-Pratt JL, Rao SL, Rainusso N, Fisher KE, Lin FY, Plon SE, Parsons DW, Roy ACancer geneticsDistinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome. Cancer Genet. 2022 04; 262-263:53-56.Cancer Genet2022-01-05T00:00:002022Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.Authorship 10396256Authorship 1040571135135432Dodson LM, Kurtz KJ, Marcogliese AN, Friend BD, Stevens AM, Fisher KEPediatric hematology and oncologyAcute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion. Pediatr Hematol Oncol. 2022 09; 39(6):580-585.Pediatr Hematol Oncol2022-02-09T00:00:002022Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion.35081690Fisher KE, Ferguson LS, Coffey AM, Merritt BY, Curry JL, Marcogliese AN, Major AM, Kamdar KY, Lopez-Terrada DH, Curry CVHaematologicaProgrammed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance. Haematologica. 2022 08 01; 107(8):1880-1890.Haematologica2022-08-01T00:00:002022Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance.35451474Woodfield SE, Mistretta BJ, Patel RH, Ibarra AM, Fisher KE, Sarabia SF, Gandhi I, Reuther J, Starosolski Z, Badachhape A, Epps J, Zorman B, Shah AP, Larson SR, Srivastava RK, Shi Y, Espinoza AF, Govindu SR, Whitlock RS, Holloway K, Roy A, Sumazin P, Ghaghada KB, Lopez-Terrada D, Gunaratne PH, Vasudevan SABiology openHepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).Biol Open2022-09-12T00:00:002022HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells.35487348Chandramohan R, Reuther J, Gandhi I, Voicu H, Alvarez KR, Plon SE, Lopez-Terrada DH, Fisher KE, Parsons DW, Roy AThe Journal of molecular diagnostics : JMDA Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels. J Mol Diagn. 2022 07; 24(7):760-774.J Mol Diagn2022-04-26T00:00:002022A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels.Authorship 10443025Authorship 1044722835577029Sumazin P, Peters TL, Sarabia SF, Kim HR, Urbicain M, Hollingsworth EF, Alvarez KR, Perez CR, Pozza A, Najaf Panah MJ, Epps JL, Scorsone K, Zorman B, Katzenstein H, O'Neill AF, Meyers R, Tiao G, Geller J, Ranganathan S, Rangaswami AA, Woodfield SE, Goss JA, Vasudevan SA, Heczey A, Roy A, Fisher KE, Alaggio R, Patel KR, Finegold MJ, L?pez-Terrada DHJournal of hepatologyHepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037.J Hepatol2022-05-14T00:00:002022Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.Authorship 104606225true1Associate ProfessorAssociate ProfessorAuthorship 10598703Authorship 10621051536102745McEvoy MT, Blessing MM, Fisher KE, Paulino AC, Nuchtern J, Chelius DC, Dimachkieh AL, Aldave G, Okcu MFPediatric blood & cancerA novel case of malignant ossifying fibromyxoid tumor with a BCOR internal tandem duplication in a child. Pediatr Blood Cancer. 2023 03; 70(3):e29972.Pediatr Blood Cancer2022-09-14T00:00:002022A novel case of malignant ossifying fibromyxoid tumor with a BCOR internal tandem duplication in a child.36346368Chen Wongworawat Y, Eskandari G, Gaikwad A, Marcogliese AN, Ferguson LS, Brackett J, Punia JN, Elghetany MT, Kulkarni R, Rao PH, Ringrose J, Lopez-Terrada DH, Roy A, Curry CV, Fisher KELeukemia & lymphomaFrequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression. Leuk Lymphoma. 2023 02; 64(2):462-467.Leuk Lymphoma2022-11-08T00:00:002022Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression.37366551Mangum R, Reuther J, Sen Baksi K, Gandhi I, Zabriskie RC, Recinos A, Raesz-Martinez R, Lin FY, Potter SL, Sher AC, Kralik SF, Mohila CA, Chintagumpala MM, Muzny D, Hu J, Gibbs RA, Fisher KE, Bernini JC, Gill J, Griffin TC, Tomlinson GE, Vallance KL, Plon SE, Roy A, Parsons DWPediatric hematology and oncologyCirculating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study. Pediatr Hematol Oncol. 2023; 40(8):719-738.Pediatr Hematol Oncol2023-06-27T00:00:002023Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.Authorship 107257317Authorship 1075551537509482Shekar M, Llaurador Caraballo G, Punia JN, Curry CV, Fisher KE, Redell MSBiomedicinesALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature. Biomedicines. 2023 Jun 27; 11(7).Biomedicines2023-06-27T00:00:002023ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature.Authorship 1089188438397996Stevens AM, Terrell M, Rashid R, Fisher KE, Marcogliese AN, Gaikwad A, Rao P, Vrana C, Krueger M, Loken M, Menssen AJ, Cook JA, Keogh N, Alozie M, Oviedo H, Gonzalez AK, Ilangovan T, Kim J, Sandhu S, Redell MSBiomedicinesAddressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine. Biomedicines. 2024 Feb 08; 12(2).Biomedicines2024-02-08T00:00:002024Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.Authorship 10903971238468555El Dana F, Garces Narvaez SA, El-Mallawany NK, Agrusa JE, Dreyer ZE, Marcogliese AN, Elghetany MT, Punia JN, Ok CY, Patel KP, Lopez-Terrada DH, Fisher KE, Curry CVPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyChildhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge. Pediatr Dev Pathol. 2024 Mar 11; 10935266241230600.Pediatr Dev Pathol2024-03-11T00:00:002024Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessor6621 FANNINHouston, 77030TX1.601050.00945301239research areas2.015430.038209589coauthor of44.1611.225160similar to1149selected publicationsAuthorship 1542291Authorship 1545132Authorship 1546393Authorship 1546431Authorship 1546541Authorship 1547862Authorship 1553751Authorship 1558623Authorship 1559491Authorship 1559834Authorship 1560212Authorship 1560801Authorship 1561421